ArticleFrontiers in oncology2022

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma.

Hongkai Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.